FDA Announces Nationwide Recall of Blood Pressure Medication Chlorthalidone
The U.S. Food and Drug Administration (FDA) has classified a nationwide recall of certain lots of chlorthalidone tablets, a medication used to treat high blood pressure, as a Class II recall. Inventia Healthcare Limited initiated the recall on September 3, following an earlier recall in June. The affected product is chlorthalidone tablets, USP, 25 mg, in 100-tablet bottles, with NDC: 64980-599-01, Batch#: RISA24002, and an expiration date of April 2027. Over 13,000 bottles are involved in this September recall. The reason for the recall is listed as 'failed dissolution specifications,' meaning the active ingredient may not dissolve properly from the tablet, potentially leading to insufficient absorption by the body. This could render the medication less effective in treating high blood pressure and reducing associated health risks.
